Benefits
Helps support a healthy lipid profile
Daily consumption of fermented rooibos tea has been associated with reductions in LDL cholesterol and triacylglycerols and increases in HDL cholesterol in adults at elevated cardiovascular risk, helping support a more favorable lipid pattern as part of an overall heart-healthy lifestyle.
Supports antioxidant defenses
Rooibos polyphenols contribute to redox balance by helping reduce markers of lipid peroxidation and supporting glutathione status in adults at risk for cardiovascular disease, complementing other dietary sources of antioxidant flavonoids.
Provides a caffeine-free beverage option
Rooibos is naturally caffeine-free and low in tannins, offering a polyphenol-rich tea alternative for people sensitive to caffeine, including those who want a calming evening beverage without disrupting sleep or fluid balance.
May support healthy glucose handling
Aspalathin and aspalathin-enriched green rooibos extracts have been studied in preclinical models for effects on insulin signaling and hepatic glucose handling, providing mechanistic rationale for interest in rooibos as part of broader metabolic-support strategies.
Mechanism of action
Polyphenol antioxidant scavenging
Aspalathin, nothofagin, and flavonoids in rooibos scavenge reactive oxygen species, chelate transition metals, and reduce lipid peroxidation, supporting cellular antioxidant defenses including glutathione-based systems in liver and vascular tissue.
Modulation of hepatic insulin signaling
Aspalathin has been shown in cellular models of hepatic insulin resistance to improve insulin signaling, energy metabolism, and mitochondrial respiration, supporting interest in rooibos polyphenols for metabolic resilience.
Angiotensin-converting enzyme modulation
Acute human studies suggest that rooibos and green tea can inhibit angiotensin-converting enzyme activity and influence nitric oxide concentrations, providing a vascular mechanism that may contribute to cardiovascular benefits over time.
Anti-inflammatory polyphenol signaling
Rooibos flavonoids modulate NF-κB-driven inflammatory signaling and downregulate cytokine production in preclinical models, supporting an anti-inflammatory contribution to cardiovascular and metabolic effects.
Clinical trials
Single-blind controlled trial of six cups of fermented rooibos tea daily for 6 weeks in adults at risk for cardiovascular disease (Marnewick et al., Journal of Ethnopharmacology).
40 volunteers at risk for cardiovascular disease.
Six weeks of fermented rooibos consumption significantly decreased LDL cholesterol and triacylglycerols and increased HDL cholesterol versus baseline, with reductions in lipid peroxidation markers and increases in glutathione status. Supports lipid and redox benefits of rooibos in adults at cardiovascular risk.
Randomized, three-phase, crossover study of single oral doses of green tea, black tea, or rooibos tea (400 mL each) with measurements of ACE activity and nitric oxide over 180 minutes (Persson et al., Public Health Nutrition).
17 healthy adult volunteers.
Green tea and rooibos tea reduced ACE activity acutely versus baseline at 30 and 60 minutes, with concurrent changes in plasma nitric oxide concentrations, supporting a vascular mechanism that may contribute to cardiovascular effects of regular rooibos consumption.
Preclinical study in palmitate-exposed C3A liver cells assessing effects of aspalathin on insulin signaling and mitochondrial bioenergetics (Mazibuko-Mbeje et al., PLoS One).
Cultured C3A hepatocytes modeling insulin resistance.
Aspalathin corrected altered substrate metabolism, improved insulin signaling, and enhanced mitochondrial bioenergetics in palmitate-exposed liver cells, providing mechanistic rationale for rooibos-derived dihydrochalcones in supporting healthy hepatic glucose handling.